Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron -- Ignore unavailable to you. Want to Upgrade?

To: SJS who wrote (230)	5/14/1998 8:58:00 AM
From: SJS	Read Replies (1) \| Respond to of 645

News! _______________ 08:38 ET Aviron (AVIR) 28 15/16: Issue indicated 1 1/4 higher after company issued release stating the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), found company's FluMist, intranasal influenza virus vaccine, provided 93% protection against culture-confirmed influenza and also provided 98% protection against influenza-associated ear infections. Throughout the entire cough, cold and flu season, children vaccinated with FluMist experienced 30% fewer ear infections with fever and a 35% reduction in related antibiotic use for ear infections with fever compared to the placebo group.